What does selank cost in each channel?
Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.
| Channel | Price (USD) | Notes |
|---|---|---|
| With insurance | Not published | Not covered. Medicare Part D and commercial pharmacy benefits cover FDA approved drugs for accepted indications; compounded or unapproved peptides are paid in cash. [3] |
| Compounded pharmacy | Not published | No lawful compounded price. FDA's list dated April 22, 2026 shows selank's 503A nomination as withdrawn, so it is in no 503A category, it was not presented at FDA's July 2026 compounding advisory committee meeting, and it is not on the 503A bulks list or a component of an approved drug, so a 503A pharmacy has no federal basis to compound it from bulk. Advertised clinic prices are not a comparable price, and products sold as research chemicals for human use are unapproved drugs. [1] [2] [4] |
Why is there no price for selank?
FDA has found a compounding pharmacy offering selank anyway. [5]
Clinics and telehealth programs may quote you a cash price for selank. PeptideAgent lists none, for two reasons. There is no selank product to price: none is FDA approved, and a pharmacy has no federal basis to compound it. [1] [2] A quoted price is for a product FDA has not checked for safety, effectiveness, or quality, so it is not the price of a reviewed drug. [6]
If you're going ahead anyway: the checklist on the selank page. These steps lower some risks. They do not make the product safe, and they do not give a pharmacy a federal basis to compound selank, with or without a prescription. [2]
- Check the pharmacy's license
- What a legitimate prescription and consult look like
- Why this is safer than a research-use-only product
- Questions to ask the pharmacy, the telehealth company, the prescriber, and anyone offering it
What is the list price of selank?
There is no US list price: selank is not an FDA approved drug. It is a registered prescription drug in Russia, and research chemical products sold for human use are unapproved drugs.
Does insurance cover selank?
Not covered by commercial plans or Medicare because it is an unapproved compounded product.
What changes the price?
- No federal basis to compound it from bulk: nomination withdrawn and not on the 503A bulks list
Frequently asked questions
How much does selank cost without insurance?
No lawful compounded price. FDA's list dated April 22, 2026 shows selank's 503A nomination as withdrawn, so it is in no 503A category, it was not presented at FDA's July 2026 compounding advisory committee meeting, and it is not on the 503A bulks list or a component of an approved drug, so a 503A pharmacy has no federal basis to compound it from bulk. Advertised clinic prices are not a comparable price, and products sold as research chemicals for human use are unapproved drugs. [1] [2] [4]
Does insurance cover selank?
Not covered by commercial plans or Medicare because it is an unapproved compounded product. [3]
What is the list price of selank?
There is no US list price: selank is not an FDA approved drug. It is a registered prescription drug in Russia, and research chemical products sold for human use are unapproved drugs.
Related pages
From the blog
- Selank nasal spray: the evidence, and combining it with semax
What the intranasal selank studies measured, whether the route matters, and what is known about semax and selank nasal spray together: no trial has tested the combination.
- Selank withdrawal: dependence, benzodiazepines, and alcohol
Does selank cause withdrawal? What studies measured on dependence, how it compares with benzodiazepines, the rodent alcohol and opioid withdrawal studies, and the untested alcohol interaction.
Sources
- [1]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (Category 2 list and withdrawn nominations, content current as of April 22, 2026)FDA
- [2]FDA: Bulk drug substances used in compounding under section 503A of the FD&C Act (links to the Category 1, 2, and 3 lists and the bulks list)FDA
- [3]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)
- [4]FDA warning letter 735063, August 24, 2026, to an online seller of research-use-only peptides: products labeled research use only were unapproved new drugs (FDA warning letters database)FDA, 2026
- [5]FDA warning letter 594743, April 1, 2020, to a state-licensed 503A compounding pharmacy (FDA warning letters database)FDA, 2020
- [6]FDA: Compounding and the FDA, questions and answersFDA